Abstract:OBJECTIVE To investigate the effect of protecting medicament of gastric mucosa on the expression of HSP 70 in rats with CAG and to elucidate the protective mechanism. METHODS CAG rats were treated with a protecting medicament of gastric mucosa. Western blot and immunohistochemistry were employed to determine the expression, contents and of distribution of HSP 70 in gastric mucosa. RESULTS ① HE analysis showed that the gland lay of CAG rats turned thinner and muscle lay became thicker with a lot of inflammation cells soakage; after natural repairing for 4 weeks, the gland lay got thicker and muscle lay turned thinner; after 24 weeks CAG rats were treated with teprenonc for 4 weeks, inflammation index decreased and the gland lay got thicker, which exhibited significant difference from 28 weeks CAG rats(natural repairing) and saline group(P0.001), but were similar with normal group; ② Immunohistochemistry showed that HSP 70 was mainly expressed in the cytoplasm of the gastric gland cells in 24 weeks, 28 weeks CAG rats and normal control group, but it was found that HSP 70 was located in both of cytoplasm and nucleus in the groups treated with protective agent and saline. The results of counting positive glands and dust-color degree demonstrated that teprenone exhibited more significant expression of HSP 70 (P0.01), compared with other groups; ③ A most significant increase for HSP 70 in the teprenone group was observed by Western blot analysis. CONCLUSION Protecting medicament of gastric mucosa (teprenone) significantly promoted the expression of HSP 70. HSP 70 was concerned with the process of the gastric mucosal repairment, and the protecting medicament of gastric mucosa may play the protective role in the press.

Effect of Protective Agent of Gastric Mucosa on Expression of Heat Shock Protein 70 in Rats with Chronic Atrophic Gastritis